Evidence map›Paper›PMID 22724499›Full record

ArticleJournal of the American Geriatrics Society2012

Effect of influenza on functional decline.

Pedro L Gozalo, Aurora Pop-Vicas, Zhanlian Feng, Stefan Gravenstein, Vincent Mor

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in Journal of the American Geriatrics Society, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01720277 phase4completednot on this map

High Dose Influenza Vaccination and Morbidity and Mortality in U.S. Nursing Homes - A Pilot Evaluation

TypeinterventionalSponsorInsight Therapeutics, LLCRan2012 to 2016Enrolled2,957ConditionsInfluenzaArmsHD Fluzone Vaccine, SD Fluzone Vaccine
NCT01815268 phase4unknown statusnot on this mapstarted 2013, after this paper: background citation

High Dose Influenza Vaccination and Morbidity & Mortality in U.S. Nursing Homes

TypeinterventionalSponsorInsight Therapeutics, LLCRan2013 to 2018Enrolled823ConditionsInfluenzaArmsHD Vaccine, SD Vaccine, Free Vaccine, Usual Care
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 81 citations in OpenAlex.

  1. Trial
  2. Article
  3. [Vaccination in old age: an overview].Zeitschrift fur Gerontologie und Geriatrie · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The dark side of Tregs during aging.Frontiers in immunology · 2022
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Influenza Infection has Fiber Type-Specific Effects on Cellular and Molecular Skeletal Muscle Function in Aged Mice.The journals of gerontology. Series A, Biological sciences and medical sciences · 2020
    Article
  16. Review
  17. Article
  18. [Respiratory viral infections (other than COVID-19)].Medecine et maladies infectieuses · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Pedro L GozaloDepartment of Health Services, Policy and Practice, Brown University, Providence, Rhode Island 02912, USA. pedro_gozalo@brown.edu
Aurora Pop-Vicas
Zhanlian Feng
Stefan Gravenstein
Vincent Mor
Brown University · US

Funding

VARIATIONS IN LIFE'S FINAL CHAPTERP01AG027296 · NIA · BROWN UNIVERSITY · PI AMAL N. TRIVEDI, Kali St. Marie Thomas · 2007 to 2026
$38.9M
State Policies and Hospitalizations from Nursing HomesR01AG020557 · NIA · BROWN UNIVERSITY · PI MOR, VINCENT · 2002 to 2004
$1.4M
The Impact of Flu and Flu Vaccine on NH Resident MorbitidityR01HS018462 · AHRQ · BROWN UNIVERSITY · PI MOR, VINCENT · 2009 to 2011
$896k
AHRQ HHS R01 HS018462AHRQ HHS R01HS018462NIA NIH HHS P01 AG027296NIA NIH HHS P01AG027296NIA NIH HHS R01 AG020557NIA NIH HHS R01AG020557
6 · The paper itself

Abstract

objectivesTo examine the relationship between influenza and activity of daily living (ADL) decline and other clinical indicators in nursing home (NH) residents.

designRetrospective NH-aggregated longitudinal study.

settingTwo thousand three hundred fifty-one NHs in 122 U.S. cities from 1999 to 2005.

participantsLong-stay (>90 days) NH residents. MEASUREMENTS: Quarterly city-level influenza mortality and state-level influenza severity. Quarterly incidence of Minimum Data Set-derived ADL decline (≥ 4 points), weight loss, new or worsening pressure ulcers (PUs), and infections. Outcome variables chosen as clinical controls were antipsychotic use, restraint use, and persistent pain.

resultsCity-level influenza mortality and state-level influenza severity were associated with higher rates of large (≥ 4 points) ADL decline (mortality β = 0.20, P < .001; severity β = 0.18, P < .001), weight loss (β = 0.19, P < .001; β = 0.24, P < .001), worsening PUs (β = 0.04, P = .08; β = 0.12, P < .001), and infections (β = 0.41, P < .001; β = 0.47, P < .001) but not with restraint use, antipsychotic use, or persistent pain. NH influenza vaccination rates were weakly associated with the outcomes (e.g., β = -0.009, P = .03 for ADL decline, β = 0.008, P = .07 for infections). Compared with the summer quarter of lowest influenza activity, the results for the other quarters translate to an additional 12,284 NH residents experiencing large ADL decline annually, 15,168 experiencing significant weight loss, 6,284 new or worsening PUs, and 29,753 experiencing infections due to influenza.

conclusionThe results suggest a substantial and potentially costly effect of influenza on NH residents. The effect of influenza vaccination on preventing further ADL decline and other clinical outcomes in NH residents should be studied further.

Indexed as

Activities of Daily LivingNursing HomesAgedAged, 80 and overFemaleGeriatric AssessmentHumansInfluenza, HumanLongitudinal StudiesMaleOutcome Assessment, Health CareRegression AnalysisRetrospective StudiesSeverity of Illness IndexSurvival RateUnited States

Identifiers

PMID22724499
PMCPMC3526071
OpenAlexW2024880060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.